These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28963882)

  • 21. A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins.
    Bredenbeek PJ; Molenkamp R; Spaan WJ; Deubel V; Marianneau P; Salvato MS; Moshkoff D; Zapata J; Tikhonov I; Patterson J; Carrion R; Ticer A; Brasky K; Lukashevich IS
    Virology; 2006 Feb; 345(2):299-304. PubMed ID: 16412488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological Characterization of Conserved Residues within the Cytoplasmic Tail of the Pichinde Arenaviral Glycoprotein Subunit 2 (GP2).
    Shao J; Huang Q; Liu X; Di D; Dileepan M; Brisse M; Ly H; Liang Y
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current research for a vaccine against Lassa hemorrhagic fever virus.
    Warner BM; Safronetz D; Stein DR
    Drug Des Devel Ther; 2018; 12():2519-2527. PubMed ID: 30147299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins.
    Wang M; Jokinen J; Tretyakova I; Pushko P; Lukashevich IS
    Vaccine; 2018 Jan; 36(5):683-690. PubMed ID: 29287681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine platforms to control Lassa fever.
    Lukashevich IS; Pushko P
    Expert Rev Vaccines; 2016 Sep; 15(9):1135-50. PubMed ID: 27136941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Mechanism for LAMP1 Recognition by Lassa Virus.
    Cohen-Dvashi H; Cohen N; Israeli H; Diskin R
    J Virol; 2015 Aug; 89(15):7584-92. PubMed ID: 25972533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lassa Virus Vaccine Candidate ML29 Generates Truncated Viral RNAs Which Contribute to Interfering Activity and Attenuation.
    Johnson DM; Cubitt B; Pfeffer TL; de la Torre JC; Lukashevich IS
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33573250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the Lassa virus GP1 ectodomain shedding: implications for improved diagnostic platforms.
    Branco LM; Garry RF
    Virol J; 2009 Sep; 6():147. PubMed ID: 19778448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive Interactome Analysis Reveals that STT3B Is Required for N-Glycosylation of Lassa Virus Glycoprotein.
    Zhu S; Wan W; Zhang Y; Shang W; Pan X; Zhang LK; Xiao G
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus.
    Morrison HG; Bauer SP; Lange JV; Esposito JJ; McCormick JB; Auperin DD
    Virology; 1989 Jul; 171(1):179-88. PubMed ID: 2741340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 25-Hydroxycholesterol Inhibition of Lassa Virus Infection through Aberrant GP1 Glycosylation.
    Shrivastava-Ranjan P; Bergeron É; Chakrabarti AK; Albariño CG; Flint M; Nichol ST; Spiropoulou CF
    mBio; 2016 Dec; 7(6):. PubMed ID: 27999160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs.
    Maruyama J; Mateer EJ; Manning JT; Sattler R; Seregin AV; Bukreyeva N; Jones FR; Balint JP; Gabitzsch ES; Huang C; Paessler S
    Vaccine; 2019 Oct; 37(45):6824-6831. PubMed ID: 31561999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Convergent Structures Illuminate Features for Germline Antibody Binding and Pan-Lassa Virus Neutralization.
    Hastie KM; Cross RW; Harkins SS; Zandonatti MA; Koval AP; Heinrich ML; Rowland MM; Robinson JE; Geisbert TW; Garry RF; Branco LM; Saphire EO
    Cell; 2019 Aug; 178(4):1004-1015.e14. PubMed ID: 31398326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages.
    Heinrich ML; Boisen ML; Nelson DKS; Bush DJ; Cross RW; Koval AP; Hoffmann AR; Beddingfield BJ; Hastie KM; Rowland MM; Aimukanova I; Koval S; Lathigra R; Borisevich V; Momoh M; Sandi JD; Goba A; Odia L; Baimba F; Aiyepada JO; Ebo B; Eromon P; Ugwu C; Folarin O; Olumade T; Onyechi MN; Etafo J; Adeyemi R; Ella EE; Aminu M; Gomerep SS; Eke MA; Ogunsanya O; Akpede GO; Asogun DO; Okogbenin SA; Okokhere PO; Holst J; Shaffer JG; Schieffelin JS; Geisbert TW; Saphire EO; Happi CT; Grant DS; Garry RF; Branco LM
    Sci Rep; 2020 Sep; 10(1):16030. PubMed ID: 32994446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of protective Lassa virus epitopes that are restricted by HLA-A2.
    Botten J; Alexander J; Pasquetto V; Sidney J; Barrowman P; Ting J; Peters B; Southwood S; Stewart B; Rodriguez-Carreno MP; Mothe B; Whitton JL; Sette A; Buchmeier MJ
    J Virol; 2006 Sep; 80(17):8351-61. PubMed ID: 16912286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccine platforms for the prevention of Lassa fever.
    Purushotham J; Lambe T; Gilbert SC
    Immunol Lett; 2019 Nov; 215():1-11. PubMed ID: 31026485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antifungal isavuconazole inhibits the entry of lassa virus by targeting the stable signal peptide-GP2 subunit interface of lassa virus glycoprotein.
    Zhang X; Tang K; Guo Y
    Antiviral Res; 2020 Feb; 174():104701. PubMed ID: 31877348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective vaccine for lassa fever.
    Fisher-Hoch SP; Hutwagner L; Brown B; McCormick JB
    J Virol; 2000 Aug; 74(15):6777-83. PubMed ID: 10888616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis of Lassa fever virus infection: I. Susceptibility of mice to recombinant Lassa Gp/LCMV chimeric virus.
    Lee AM; Cruite J; Welch MJ; Sullivan B; Oldstone MB
    Virology; 2013 Aug; 442(2):114-21. PubMed ID: 23684417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lamp1 Increases the Efficiency of Lassa Virus Infection by Promoting Fusion in Less Acidic Endosomal Compartments.
    Hulseberg CE; Fénéant L; Szymańska KM; White JM
    mBio; 2018 Jan; 9(1):. PubMed ID: 29295909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.